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ABSTRACT
Background and Objective: Although laparoscopic sur-
gery for removal of adnexal masses is common, contro-
versy exists about the safety and efficacy of this proce-
dure for patients with malignancies. The aim of this study
was to evaluate the effectiveness and safety of laparo-
scopic surgical treatment for patients with adnexal mass-
es. 
Methods: This was a retrospective chart review of one
surgeon’s experience in managing patients diagnosed
with adnexal masses at 2 urban referral teaching hospi-
tals in New York City. We reviewed the charts for 100
consecutive patients who underwent operative
laparoscopy for management of adnexal masses between
March 4, 1996 and November 9, 1998. Conversion to
laparotomy, malignancy rate, complications, length of
stay, and blood loss were recorded for each patient.
Results: Laparoscopic management was successfully
completed for 81 of the 100 patients in this study; how-
ever, 19 required conversion to laparotomy. All 81
patients managed laparoscopically had a benign diagno-
sis, whereas 7 of the 19 patients who underwent laparo-
tomy were diagnosed with malignancy. The median
length of stay, estimated blood loss, and operating room
time were significantly lower for those treated by
laparoscopy alone compared with those converted to
laparotomy (2 vs. 7 days; 100 vs. 500 ccs; 130 vs. 235
minutes, respectively; P < 0.05). Though few patients
were in the laparotomy group, that data are presented for
completeness. A total of 10 complications occurred, 4 in
INTRODUCTION
Laparoscopic management of adnexal masses is common
in the United States, yet remains controversial due to
conflicting research reports and rapid advances in tech-
nology and skill.1-4 Although treating benign adnexal
masses laparoscopically has become the standard of
care,5-14 managing suspected or known malignancies
laparoscopically is an area with many unanswered ques-
tions and concerns.1-3,11,15-21 Potential problems previ-
ously cited in the literature include lack of appropriate
use of frozen sections intraoperatively,22 trocar site
abdominal wall tumor implantation,23,24 and inappropri-
ate or inadequate staging of malignancies at the time of
laparoscopy.22
The aim of this study was to assess the effectiveness of
laparoscopic management of adnexal masses with
unknown pathology in a recent series of consecutive
patients. The focus was on pathology findings, length of
stay, operating room time, complications, and laparoto-
my conversion rate.
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the group of patients managed laparoscopically (2
enterotomies, 1 pneumothorax, and 1 vaginal cuff cel-
lulitis). Six complications occurred in those managed
with laparotomy (2 enterotomies, 2 wound infections, 1
pneumonia, and 1 postoperative fever). The indications
for conversion to laparotomy were: 7 malignancies (5
ovarian cancers and 2 uterine cancers), 7 dense adhe-
sions, 2 small bowel enterotomies, 1 intraoperative
bleeding, 1 secondary to a large uterus (880 grams), and
1 secondary to a large myoma (13 cm x 14.5 cm x 6 cm).
Conclusions: The laparoscopic approach is effective
and safe for managing patients with adnexal masses of
unknown pathology. Malignancies can be diagnosed
accurately, converted to laparotomy, and staged appro-
priately. Adequate surgical skills along with timely use of
frozen sections are required for successful operative
management.
Key Words: Adnexal diseases-diagnosis-surgery,
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MATERIAL AND METHODS
This was an observational, retrospective chart-review
study of patients clinically diagnosed with an adnexal
mass. The inclusion criteria were: women who under-
went laparoscopic surgery performed by, or under direct
supervision of, the primary author (ES) for management
of suspected adnexal masses during the 32-month study
period, March 4, 1996 to November 9, 1998. Suspected
adnexal or pelvic masses were, in general, defined as
those with abnormal appearance on radiographic exami-
nation (ultrasound or CT scan) with the following char-
acteristics: persistent cystic masses larger than 3 cm, with
or without septations, papillations, or solid components.
No patients were excluded preoperatively for elevated
serum CA-125 concentrations or abnormal radiographic
characteristics of the mass alone. Patients with complex
masses, ascites, and elevated serum CA-125 levels were
excluded from the laparoscopic approach due to the high
probability of a malignant condition. No patients during
this study period who were eligible for laparoscopic sur-
gery requested laparotomy as the initial treatment. All
procedures were performed at either The Brooklyn
Hospital Center in Brooklyn, New York or Saint Vincent’s
Hospital Medical Center located in Staten Island, New
York. The second author (PLE, a fourth-year medical stu-
dent at the time) performed the chart review between
November 9, 1998 and December 10, 1998. The third
author (DWB) performed the statistical analysis. All
patients provided a history and underwent a physical
examination prior to surgery. The following variables
were abstracted from the medical records: age, weight,
height, length of stay, estimated blood loss, pathology
findings, complications, and reasons for conversion to
laparotomy.
Ascites was defined as an abnormal accumulation of
serous fluid in the peritoneal cavity, identified on physi-
cal examination as a positive fluid wave, and confirmed
preoperatively by CT scan or ultrasound. Complications
were defined as pneumothorax, confirmed by chest x-
ray; wound infection, occurring within 14 days postoper-
atively, and confirmed by positive wound cultures; post-
operative fever, a documented temperature of 38.3° C
occurring postoperatively within 48 hours; enterotomy,
defined as incision of the small intestines; vaginal cuff
cellulitis, defined clinically by elevated temperature
(greater than 38.3° C), pelvic tenderness, vaginal cuff dis-
charge and induration; and pneumonia, confirmed by
chest x-ray.
All patients were placed on a clear-liquid diet 24 hours
prior to surgery. A mechanical bowel preparation,
including 2 to 4 liters of polyethylene glycol-electrolyte
solution (Golytely, Braintree Laboratories, Braintree, MA)
by mouth, or 8 oz of magnesium citrate, and a prepack-
aged monobasic and dibasic sodium phosphate enema
(Fleet, C.B. Fleet Co. Inc.) were administered the evening
before surgery. Cefazolin (Schein Pharmaceuticals,
Florham Park, NJ) 1 to 2 g was administered preopera-
tively via intravenous piggyback. In patients with sensi-
tivity to cephalosporins, Cleocin phosphate (Pharmacia
and Upjohn, Kalamazoo, MI) 600 mg intravenous piggy-
back was administered preoperatively.
The initial laparoscopic procedure was consistent for all
patients. Once on the operating table, patients were
placed in a supine position with legs in Allen laparo-
scopic stirrups (Allen Medical Systems, Cleveland, OH),
and with arms at their side. Bilateral thigh-high antiem-
bolic compression stockings (TED stockings) and pneu-
matic compression stockings (Kendall sequential com-
pression sleeves, The Kendall Co., Mansfield, MA) were
applied. A urinary catheter was inserted. All procedures
were performed in the inpatient operating suite. All
patients received nonnitrous general anesthesia and
underwent endotracheal intubation. A standard 4-trocar
technique was used. A 12-mm Ethicon Endopath
Optiview (Ethicon Endo-Surgery, Inc. Cincinnati, Ohio)
was used to gain direct access into the peritoneal cavity
via an infraumbilical or supraumbilical incision (this tech-
nique was used for 78 patients). This was followed by
two 5-mm ports placed under direct laparoscopic visual-
ization at the right and left lower quadrant and a 12-mm
port placed 2 cm above the symphysis pubis. Hasson
open laparoscopic technique was generally used in
patients with multiple previous surgeries (this technique
was used for 22 patients).25-27 Carbon dioxide insufflation
pressures of 15 mm Hg were maintained during the pro-
cedure. The patients were placed and maintained in a 30-
degree Trendelenburg position. Diagnostic laparoscopic
inspection of all peritoneal surfaces was performed, fol-
lowed by adhesiolysis using sharp dissection. In patients
with suspicious-appearing masses (ie, tumor excres-
cences on the surface of the ovary, uterus, or peritoneal
implants) frozen section biopsy specimens were
obtained. If a malignancy was confirmed, immediate
laparotomy, and surgical staging was performed by the
primary author (ES). In patients with benign-appearing
masses (ie, cystic lesions with smooth surfaces) an
attempt was made to resect the mass intact and place itin an Endopouch Pro specimen-retrieval bag (Ethicon
Endo-Surgery, Inc. Cincinnati, OH). Aspiration of the
mass was then performed prior to its removal from the
abdominal cavity. Benign-appearing masses that were
too large to be removed intact via the Endopouch were
aspirated, placed in the Endopouch and removed. All
specimens were then sent to the pathology department
for diagnostic evaluation. 
Informed consent was obtained from each patient for the
procedure, which included a statement describing the
possibility and consequences of conversion to laparoto-
my. Because this was a retrospective chart-review study,
additional study consent and Institutional Review Board
approval were not required. 
All patients were seen and examined postoperatively at
2 and 6 weeks. The 93 patients with benign disease were
then referred back to their primary physicians for further
follow-up care. Of the 7 patients with malignant pathol-
ogy, 6 were followed by the primary author, and exam-
ined every 3 to 6 months, with 1 patient lost to follow-
up.
Serum CA-125 analyses were performed at Smith-Kline-
Beecham laboratories in Syosset, New York. Values were
established by a classical solid-phase immunoradio-met-
ric assay. Levels below 35 U/mL were considered nor-
mal.
Statistical Analysis
Categorical variables were assessed with the chi-square
or Fisher’s exact test. For comparisons across the 3 years
of the study, the Mantel-Haenszel test for a linear associ-
ation was used. Continuous variables that were normally
distributed, such as age, height, and weight, are present-
ed as means and standard deviations. These variables
were assessed with a Student’s t-test. If variables were
not normally distributed (such as length of stay), the
median was presented and comparisons were made with
the Mann-Whitney U test. The statistical software SPSS
version 9.0 (SPSS Inc., Chicago, IL) was used for all
analyses. All tests are two-tailed and P values less than
0.05 were considered statistically significant.
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RESULTS
Conversion to Laparotomy
Of the 100 patients who met the inclusion criteria for this
study, 19 required conversion to laparotomy. As expect-
ed, the outcome variables, such as estimated blood loss,
operating room time, and length of stay, were signifi-
cantly different in those patients converted to laparotomy
(Table 1). 
Of the 19 patients converted to laparotomy, 7 conver-
sions were due to malignancies, 7 to dense adhesions, 2
Table 1.
Comparison of patients with laparoscopic management of
adnexal masses with those requiring conversion to laparotomy.
Laparoscopic Laparotomy P Value
(n=81) (n=19)
Age (yrs) mean ± SD 48.2 ± 14.0 49.4 ± 15.1 0.743
range 17 - 80 22 - 79
Height (cm) mean ± SD 159 ± 7 157 ± 6.5 0.218
Range 142 - 175 148 - 170
Weight (kg) mean ± SD 73.5 ± 21.5 73.3 ± 15.6 0.983
range 32.3 - 141 43 - 105
Menopausal status 0.504
Premenopausal 40 (49.4%) 11 (57.9%)
Postmenopausal 41 (50.6%) 8 (42.1%)
Brooklyn Hospital Ctr 47 (58.0%) 17 (89.5%) 0.010
St Vincent’s Med Ctr 34 (42.0%) 2 (10.5%)
Year of the procedure 0.008
1996 9 (11.1%) 8 (42.1%)
1997 26 (32.1%) 4 (21.1%)
1998 46 (56.8%) 7 (36.8%)
Estimated blood loss
(cc) median  100 500 <0.001
range 5 - 500 100 - 1500
Operating room time
(min) median 130 235 <0.001
median hours/minutes 2 hrs/10 min 3 hrs/55 min
range 55 - 285 75 - 325
Length of stay (days)
median 2.0 7.0 <0.001
range 0.5 - 6.0 3 - 12
Ascites 2 (2.5%) 0 (0.0%) 1.000
Complications 4 (4.9%) 6 (31.6%) 0.003Laparoscopic Management of Adnexal Masses, Serur E et al.
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to small bowel enterotomies (associated with trocar
placement), 1 secondary to extensive bleeding, 1 sec-
ondary to a large uterus (880 grams), and 1 secondary to
a large myoma (13 cm x 14.5 cm x 6 cm). To assess the
learning curve of the laparoscopic technique, we com-
pared the data from the surgeries performed in the first
half of the study (the first 50 patients by date of surgery)
with the second half (the second 50 patients). Estimated
blood loss was slightly lower in the second half. The con-
version to laparotomy rate was lower in the second half,
12% vs. 26%, P = 0.074. The percentage with malignan-
cies was also lower in the second half, 4% vs. 10%, P =
0.240. The complication rate was lower in the first half,
8% vs. 12%, P = 0.505. Length of stay and operating room
time did not change over the course of the study.
Outcome
A total of 10 complications occurred in this series of
patients. Four complications occurred in the 81 patients
managed laparoscopically. Two patients incurred entero-
tomies as a result of trocar placement. Both patients had
extensive adhesions secondary to previous abdominal
surgeries and required conversion to laparotomy for
enterotomy repair. One pneumothorax that occurred dur-
ing surgery presented as decreased oxygen saturation
along with elevated ventilation pressures. A chest x-ray in
the recovery room later confirmed pneumothorax. The
patient was treated with a chest tube for 24 hours and
was discharged home on postoperative day 6 with no fur-
ther sequelae. The etiology of the pneumothorax is
unknown. The patient was a frail female with kyphosis
and scoliosis. No difficulty occurred with intubation and
no known history of lung disease existed. One patient
developed vaginal cuff cellulitis. She presented to the
emergency department 21 days postoperatively with vagi-
nal bleeding, fever, and abdominal pain for 2 days. She
was admitted to the hospital for 5 days and treated 
with ampicillin sodium (Apothecon Co., Bristol-Meyers
Squibb Co, Princeton, NJ), gentamicin sulfate (SoloPak
Laboratories, Inc., Boca Raton, FL) and metronidazole
(SCS Pharmaceuticals, Chicago, IL).
Six complications occurred among the 19 patients who
required conversion to laparotomy. One patient devel-
oped right lower lobe pneumonia, required intravenous
antibiotics, and was discharged on postoperative day 6
on oral antibiotics. One patient developed fever (39° C)
36 hours postoperatively. She was started on gentamicin
and clindamycin; all diagnostic tests for sepsis (including
chest x- ray, complete blood count, and blood, urine,
and sputum cultures) were negative. No further investi-
gations were done, and the patient was discharged home
on postoperative day 5. Two patients experienced inci-
dental enterotomies after conversion to laparotomy. Both
patients had extensive endometriosis associated with
multiple adhesions. Two patients developed wound
infections and were managed at home with oral antibi-
otics and dressing changes by visiting nurses. Pathology
data include benign conditions in 12 of 19 (63%) and
malignancies in 7 of 19 patients (37%) (Table 2). Four
patients had endometriosis, 5 had ovarian cancer, 2 had
uterine cancer, 3 had tubo-ovarian abscesses (TOA), 1
had a serous cyst, and 1 had tubo-ovarian complex
(TOC). 
Of the 7 patients with malignancies, 1 was lost to follow-
up 9 months after treatment (stage IV postradiation uter-
ine sarcoma). Four of the 5 patients with ovarian cancer
were treated with 6 cycles of paclitaxel (Taxol, Mead-
Table 2. 
Pathology of suspected adnexal masses for the two groups.
Histologic diagnosis Laparoscopic Laparotomy Total
(N=81) (N=19) (N=100)
Serous cyst 21 1 22
Endometriosis 11 4 15
Dermoid cyst 11 3 14
TOA 6 3 9
TOC 6 1 7
Hemorrhagic corpus
luteum cyst 7 7
Ovarian cancer 5 5
Uterine cancer 2 2
Hydrosalpinx 3 3
Follicular cyst 3 3
Paratubal cyst 3 3
Fibroids 3 3
Hematosalpinx 1 1
Torsion 1 1
Lymphocyst 1 1
Thecoma 1 1
Morgagni cyst 1 1
TOA/TOC 1 1
Brenner tumor 1 1JSLS(2001)5:143-151 147
Johnson Oncology Products) and Paraplatin (carboplatin,
VHA Plus Inc.) chemotherapy. One patient with stage Ic
granulosa cell tumor did not receive chemotherapy. One
patient (stage IIIc papillary serous cystadenocarcinoma)
subsequently relapsed at 18 months after her initial diag-
nosis and received additional chemotherapy. The
remaining 5 patients are alive with no evidence of dis-
ease at 14, 28, 36, 37, and 40 months after surgical treat-
ment. 
Pathology
All 81 patients treated laparoscopically had benign dis-
ease (Table 2). The more common pathology findings
include 21 serous cysts, 7 hemorrhagic corpus luteum
cysts, 6 tubo-ovarian complexes, and 6 tubo-ovarian
abscesses. For the 7 patients with malignancies, a more
detailed description of the pathology is provided in
Table 3. The 7 patients with malignancies were different
from the 93 without malignancies in several ways. They
were treated earlier in the 3-year study period, and they
were older (57.0 vs. 47.8 years). The proportion with
malignancies was 17.6% in 1996, 6.7% in 1997, and 3.8%
in 1998, P = 0.069. Among the postmenopausal women,
10.4% had malignancies vs. 3.9% in premenopausal
women. A malignancy rate of 9.4% existed at The
Brooklyn Hospital Center compared with 2.8% at Saint
Vincent’s Hospital, P = 0.215.
Preexisting Conditions and Previous Surgery
Of the 100 patients in this study, 12 had undergone pre-
vious hysterectomy. During the study, 39 patients under-
Table 3.
Pathology of Malignant Tumors.
Type Histologic Diagnosis Total N
Ovarian 5/7 71%
Granulosa cell tumor, stage Ic  1
Papillary serous cystadenocarcinoma, stage IIIa, grade 2 1
Papillary serous cystadenocarcinoma, stage IIIc 1
Well differentiated endometrioid adenocarcinoma, stage Ic 1
Mixed serous adenocarcinoma granulosa cell tumor, stage IIa grade 3 1
Uterine 2/7 29%
Post radiation sarcoma, stage IV 1
Low grade sarcoma, stage IIIa 1
went hysterectomy (11 total abdominal hysterectomies
and 28 laparoscopic-assisted vaginal hysterectomies).
The mean uterine weight associated with total abdominal
hysterectomy was 298 g (range 25 to 880 g), and the
mean uterine weight associated with laparoscopic-assist-
ed vaginal hysterectomy was 202 g (range 59 to 450 g, 
P = 0.107). 
Two patients had ascites preoperatively, both associated
with cirrhosis. The first patient, a 58-year-old female, was
admitted with a diagnosis of pelvic mass and a serum
CA-125 level of 700 U/mL. A CT scan of the abdomen
and pelvis revealed a left plural effusion, ascites, and a
simple 4.5-cm adnexal cystic mass. She had a past med-
ical history of Hodgkin’s lymphoma and hepatitis 30
years previously. Review of serial CT scans revealed a
stable cystic pelvic mass present for 3 years, with new
onset of ascites. Diagnostic laparoscopy was performed
and confirmed a serous cyst adenoma with ascites sec-
ondary to cirrhosis. The patient was managed with
diuretics and discharged home uneventfully. The second
patient, a 47-year-old female, was admitted with a diag-
nosis of menorrhagia, chronic pelvic pain, and a pelvic
mass with a serum CA-125 level of 11 U/mL. A CT scan
of the abdomen and pelvis revealed a left cystic structure
4 cm x 5 cm and ascites. She had a past medical history
of insulin-dependent diabetes mellitus for 11 years,
hypertension, angina, arthritis, and ethanol abuse.
Diagnostic laparoscopy confirmed alcoholic cirrhosis and
a left adnexa with a hemorrhagic corpus luteum cyst. 
A total of 32 of the 100 patients had serum CA-125 val-
ues obtained within 1 month prior to surgery. Of the 51Laparoscopic Management of Adnexal Masses, Serur E et al.
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premenopausal patients, 11 had a documented serum
CA-125 level, 6 of which were elevated. Only 1 of the 6
elevated levels was associated with ovarian cancer,
whereas 21 of the 49 postmenopausal patients had a doc-
umented serum CA-125 level, 8 of which were elevated.
Only 4 of the 8 elevated levels were associated with
malignancies, all of which were ovarian in origin. All 5
patients with ovarian cancer had elevated serum CA-125
levels preoperatively with the following values, 37, 185,
469, 488, and 1022 U/mL.
Of the 100 patients in this study, 70 had had previous
abdominal surgery. The proportion with previous surgery
was not statistically different between those managed
with laparoscopy versus laparotomy (P = 0.579). Among
the 19 patients converted to laparotomy, 2 of 7 patients
(29%) with malignancies had had previous abdominal
surgery, whereas 10 of 12 patients (83%) with benign
pathology had had previous abdominal surgeries. Of
those managed with laparotomy, the proportion with pre-
vious surgery was higher in patients with benign pathol-
ogy compared with those with a malignant pathology 
(P = 0.045).
DISCUSSION
Operative laparoscopy was first performed in 1901 by
Georg Kelling28 with an endoscope on a live dog. Since
then, laparoscopists have continually redefined the
boundaries for safe and effective use of this tool.
Laparoscopic management of malignant ovarian lesions
needs further exploration and research with a possible
role for this modality in both early-stage disease and sec-
ond-look operations.1,3,23,24,29 The accepted standard of
care at this time, which we support, is that known ovari-
an malignancies should be managed with laparotomy.30,31
Whether adnexal lesions that are not clearly benign or
malignant can be managed safely with laparoscopic tech-
niques is a timely and important question to answer.
Our study supports the use of operative laparscopy for
the management of adnexal masses with unknown
pathology. We observed that all 7 patients with malig-
nancies were accurately diagnosed at the time of
laparoscopy, converted to laparotomy, and appropriately
staged. 
To evaluate technical improvement in laparoscopy skills,
data from the first half of the study was compared with
data from the second half. The length of stay and opera-
tive time did not change during the study. The estimated
blood loss was slightly less in the second half of the
study. However, a decreasing trend was established for
both conversion to laparotomy (26% vs. 12%) and malig-
nancy rate (10% vs. 4%) during the second half of the
study (statistical significance was not reached most like-
ly because of the result of the small number of patients
in this group). We attribute this progressive decrease in
malignancy to improved patient selection.
Although analysis of the full learning curve would be
ideal to assess technical improvement, for statistical
power we opted to compare data from the first half of
the study to data from the second half. The length of stay
and operative time did not change during the study. The
complication rate was slightly lower in the first half of the
study, but did not reach statistical significance. We attrib-
ute this trend to laparoscopic management of more com-
plex patients. The conversion-to-laparotomy rate was
lower in the second half of the study, 12% vs. 26%, P =
0.074. We attribute this change to increased technical
skills. The malignancy rate was lower in the second half,
4% vs. 10%, P = 0.240. We attribute this change to an
improved patient selection process. Our data reflect a
learning curve associated with managing more compli-
cated patients and more appropriate patient selection. 
Parker2 has reported on the importance of careful patient
selection, proper intra-operative assessment and liberal
use of rapid frozen sections for appropriate management
of adnexal masses via operative laparoscopy. Nezhat32
states that experienced surgeons using intraoperative his-
tologic sampling may safely evaluate adnexal masses
laparoscopically. Canis et al33 reported results of a study
of 757 patients with 819 masses that were managed
laparoscopically. Seven ovarian cancers and 12 tumors of
low malignant potential (12.5%) existed. This resulted in
a sensitivity of 100% in the laparoscopic diagnosis of
malignancy, a specificity of 96.6%, and a negative pre-
dictive value of 100%. Using cautious management and
strict guidelines, laparoscopic diagnosis of adnexal mass-
es appears reliable and safe, allowing for immediate and
adequate surgical treatment of malignancies. Careful pre-
operative assessment will reduce the possibility of inad-
vertently encountering malignancy, but will not entirely
eliminate the risk.22 With careful patient selection, prop-
er technique, an experienced operator, and informed
consent to proceed to laparotomy if required, laparo-
scopic treatment of adnexal masses is advisable.9We  found that patients undergoing successful laparo-
scopic management enjoyed a decreased length of stay,
operative time, and estimated blood loss. Pittaway et al8
compared laparoscopic adnexal excision with conven-
tional laparotomy and concluded that the laparoscopic
approach offers significant advantages to laparotomy in
selected patients when performed by a laparoscopist
experienced in advanced techniques. Statistically signifi-
cant differences were reported for operative time, esti-
mated blood loss, length of stay, total cost, and recovery
time. 
Our overall conversion-to-laparotomy rate was 19% (26%
for the first half of the study and 12% for the second
half). We believe this high rate of conversion is due to a
combination of factors. First, a learning curve must be
established and traversed to acquire the technical skills
necessary to perform these procedures laparoscopically.
For example, a small enterotomy during the first half of
the study would have required conversion to laparoto-
my, whereas in the later half of the study this could be
managed laparoscopically. Similarly, the laparscopic
management of intraabdominal adhesions, intraabdomi-
nal bleeding, and large pelvic masses was improved as
technical skills were acquired. Second, improved patient
selection during the second half of the study led to a
decreased conversion rate secondary to malignancies.
The use of CA-125 values, especially in the post-
menopausal patient, in conjunction with a suspicious
radiographic study was often initially managed with
laparotomy in the second half of the study. Finally, the
patient populations in the 2 hospitals were quite differ-
ent. The Brooklyn Hospital Center, with a laparotomy
conversion rate of 26.5%, serves an inner-city population
with limited health care access and a high rate of ovari-
an neoplasm with infectious etiology, such as tubo-ovar-
ian complex and pelvic inflammatory disease. These
masses are technically difficult to manage laparoscopi-
cally, whereas Saint Vincent’s Hospital, with a conversion
rate of 5.5%, serves a middle-class suburban population
with much less ominous pathology that is easier to resect
laparoscopically. This diversity in patient population also
plays a major role in the discrepancy in conversion to
laparotomy for malignancy rate between The Brooklyn
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Hospital Center, which was 9.4%, and Saint Vincent’s
Hospital, which was 2.8%.
The increased operative time in our study not only
reflects the degree of technical difficulty but also the
varying pathology encountered in our patient population
including tubo-ovarian complex and tubo-ovarian
abscess. In addition, many of our patients underwent a
hysterectomy at the time of laparscopy, whereas in other
studies only the adnexal lesions were managed laparo-
scopically.
The 10% complication rate in our study was comparable
to that of others. Infection was the most common com-
plication, followed by small bowel enterotomy. This
translates to a mild increase in length of stay. A higher
complication rate was associated with laparotomy vs.
laparoscopic management. Furthermore, 2 patients treat-
ed with laparotomy were at high risk for developing
severe complications secondary to previous pelvic radia-
tion. Both patients developed complications, 1 wound
infection and 1 small bowel enterotomy. We believe that
incorporating the following methods will decrease the
complication rate in the future: use of the Hasson open
laparoscopic technique for all patients with any previous
abdominal surgery,26,27,34 careful attention to good surgi-
cal technique, and efficient completion of procedures in
a timely fashion.
We  found that laparoscopic management of adnexal
masses with unknown pathology was effective in remov-
ing benign lesions and in identifying patients with malig-
nancies who required conversion to laparotomy. Long-
term follow-up studies are now needed to assess the sur-
vival of these patients. 
CONCLUSION
In conclusion, the laparoscopic approach is effective and
safe for managing patients with adnexal masses of
unknown pathology. Malignancies can be diagnosed
accurately, converted to laparotomy, and staged appro-
priately. Adequate surgical skills along with timely use of
frozen sections are required for successful operative
management.Laparoscopic Management of Adnexal Masses, Serur E et al.
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